Style | Citing Format |
---|---|
MLA | Khalili N, et al.. "Seroprevalence of Anti-Toxocara Antibody Among Multiple Sclerosis Patients: A Case–Control Study." Journal of Parasitic Diseases, vol. 44, no. 1, 2020, pp. 145-150. |
APA | Khalili N, Khalili N, Nickhah A, Khalili B (2020). Seroprevalence of Anti-Toxocara Antibody Among Multiple Sclerosis Patients: A Case–Control Study. Journal of Parasitic Diseases, 44(1), 145-150. |
Chicago | Khalili N, Khalili N, Nickhah A, Khalili B. "Seroprevalence of Anti-Toxocara Antibody Among Multiple Sclerosis Patients: A Case–Control Study." Journal of Parasitic Diseases 44, no. 1 (2020): 145-150. |
Harvard | Khalili N et al. (2020) 'Seroprevalence of Anti-Toxocara Antibody Among Multiple Sclerosis Patients: A Case–Control Study', Journal of Parasitic Diseases, 44(1), pp. 145-150. |
Vancouver | Khalili N, Khalili N, Nickhah A, Khalili B. Seroprevalence of Anti-Toxocara Antibody Among Multiple Sclerosis Patients: A Case–Control Study. Journal of Parasitic Diseases. 2020;44(1):145-150. |
BibTex | @article{ author = {Khalili N and Khalili N and Nickhah A and Khalili B}, title = {Seroprevalence of Anti-Toxocara Antibody Among Multiple Sclerosis Patients: A Case–Control Study}, journal = {Journal of Parasitic Diseases}, volume = {44}, number = {1}, pages = {145-150}, year = {2020} } |
RIS | TY - JOUR AU - Khalili N AU - Khalili N AU - Nickhah A AU - Khalili B TI - Seroprevalence of Anti-Toxocara Antibody Among Multiple Sclerosis Patients: A Case–Control Study JO - Journal of Parasitic Diseases VL - 44 IS - 1 SP - 145 EP - 150 PY - 2020 ER - |